Screening and identification of novel milk‐derived α ‐glucosidase inhibitory peptides: insights from molecular docking, molecular dynamics modeling, and network pharmacology
Journal of the Science of Food and Agriculture · 2026-12 · 106 (15) · 9282-9297
DOI: 10.1002/jsfa.70897 ↗At a glance
Journal article in Journal of the Science of Food and Agriculture, published online on 2026-07-26. Written by Jiayi Zhao and 4 co-authors. Institution: Food College, Northeast Agricultural University, Harbin, China. Major MEDLINE topics: Glycoside Hydrolase Inhibitors, Peptides, Milk, Milk Proteins. 47 references. Funded by: Natural Science Foundation of Heilongjiang Province.
Abstract (original language)
BACKGROUND Milk‐derived α ‐glucosidase‐inhibiting peptides are attracting increasing attention from the scientific community because of their exceptional biological activity and excellent safety profile. However, the differences in inhibitory activity among peptides from various milk protein sources remain unclear. In this study, a novel α ‐glucosidase inhibitory peptide was screened from milk protein hydrolysates derived from different sources and subsequently validated in vitro . RESULTS The results obtained indicate that the peptide fraction derived from bovine casein hydrolyzed by alkaline protease exhibited the strongest enzyme inhibitory effect (IC 50 = 0.87 ± 0.02 mg mL −1 ). Through mass spectrometry identification combined with molecular docking and molecular dynamics simulations, it was found that the peptide segment FRQFYQL can stably bind to α ‐glucosidase via hydrogen bonds and hydrophobic interactions (−11.2 kcal mol −1 ). The in vitro experiments revealed that the inhibitory activity of this peptide (IC 50 = 0.35 ± 0.04 mg mL −1 ) was higher than that of the original hydrolysate. Furthermore, FRQFYQL significantly increased glucose absorption and glycogen production in insulin‐resistant HepG2 cells. Network pharmacology analysis suggested that FRQFYQL may improve glucose metabolism‐related complications by regulating signaling pathways such as TNF and IL‐17, thereby reducing cellular glucose levels and pro‐inflammatory factor expression. CONCLUSION The peptide FRQFYQL effectively inhibits α ‐glucosidase activity, and enhances cellular glucose uptake and glycogen synthesis, thus demonstrating potential as a hypoglycemic component in functional foods and nutraceuticals. © 2026 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Food College, Northeast Agricultural University, Harbin, China.
- Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin, China.
ORCID profiles: Xiaodong Li
Funding
- Natural Science Foundation of Heilongjiang Province
Cite
APA
Zhao, J., Xu, Y., Liu, L., Li, X., & Zhang, X. (2026). Screening and identification of novel milk‐derived α ‐glucosidase inhibitory peptides: insights from molecular docking, molecular dynamics modeling, and network pharmacology. Journal of the Science of Food and Agriculture, 106(15), 9282-9297. https://doi.org/10.1002/jsfa.70897
Vancouver
Zhao J, Xu Y, Liu L, Li X, Zhang X. Screening and identification of novel milk‐derived α ‐glucosidase inhibitory peptides: insights from molecular docking, molecular dynamics modeling, and network pharmacology. Journal of the Science of Food and Agriculture. 2026;106(15):9282-9297. doi:10.1002/jsfa.70897
BibTeX
@article{Zhao2026,
author = {Zhao, Jiayi and Xu, Yanling and Liu, Lu and Li, Xiaodong and Zhang, Xiuxiu},
title = {Screening and identification of novel milk‐derived α ‐glucosidase inhibitory peptides: insights from molecular docking, molecular dynamics modeling, and network pharmacology},
journal = {Journal of the Science of Food and Agriculture},
year = {2026},
volume = {106},
number = {15},
pages = {9282--9297},
doi = {10.1002/jsfa.70897}
}
EUVIMED